Summit Place Financial Advisors LLC Sells 495 Shares of Addus HomeCare Co. (NASDAQ:ADUS)

Summit Place Financial Advisors LLC reduced its position in shares of Addus HomeCare Co. (NASDAQ:ADUS) by 5.0% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 9,330 shares of the company’s stock after selling 495 shares during the quarter. Summit Place Financial Advisors LLC owned 0.05% of Addus HomeCare worth $1,241,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Texas Permanent School Fund Corp lifted its position in Addus HomeCare by 0.6% during the second quarter. Texas Permanent School Fund Corp now owns 14,089 shares of the company’s stock valued at $1,636,000 after purchasing an additional 82 shares in the last quarter. Arizona State Retirement System increased its holdings in Addus HomeCare by 2.0% in the 2nd quarter. Arizona State Retirement System now owns 4,543 shares of the company’s stock worth $527,000 after acquiring an additional 87 shares in the last quarter. UMB Bank n.a. raised its stake in Addus HomeCare by 64.2% during the 2nd quarter. UMB Bank n.a. now owns 225 shares of the company’s stock worth $26,000 after acquiring an additional 88 shares during the period. Inspire Investing LLC boosted its position in shares of Addus HomeCare by 3.3% in the third quarter. Inspire Investing LLC now owns 3,111 shares of the company’s stock worth $414,000 after purchasing an additional 100 shares during the period. Finally, Azzad Asset Management Inc. ADV increased its stake in shares of Addus HomeCare by 1.3% in the second quarter. Azzad Asset Management Inc. ADV now owns 8,436 shares of the company’s stock worth $980,000 after purchasing an additional 110 shares in the last quarter. Hedge funds and other institutional investors own 95.35% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have issued reports on ADUS shares. Royal Bank of Canada reiterated an “outperform” rating and issued a $141.00 price target on shares of Addus HomeCare in a research note on Tuesday, September 3rd. TD Cowen lifted their target price on Addus HomeCare from $128.00 to $137.00 and gave the company a “buy” rating in a research note on Thursday, August 8th. Oppenheimer upped their price target on Addus HomeCare from $140.00 to $145.00 and gave the stock an “outperform” rating in a research note on Monday, September 23rd. Macquarie reiterated an “outperform” rating and set a $139.00 price objective on shares of Addus HomeCare in a research report on Friday, October 11th. Finally, Stephens restated an “overweight” rating and set a $138.00 target price on shares of Addus HomeCare in a research report on Tuesday, August 6th. One analyst has rated the stock with a sell rating, eight have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $131.38.

Insiders Place Their Bets

In other news, EVP Michael D. Wattenbarger sold 21,917 shares of the firm’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $133.29, for a total value of $2,921,316.93. Following the completion of the sale, the executive vice president now owns 7,215 shares in the company, valued at approximately $961,687.35. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Addus HomeCare news, Director Esteban Lopez sold 500 shares of the stock in a transaction on Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total value of $63,750.00. Following the sale, the director now owns 3,366 shares in the company, valued at $429,165. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Michael D. Wattenbarger sold 21,917 shares of Addus HomeCare stock in a transaction on Monday, August 26th. The stock was sold at an average price of $133.29, for a total value of $2,921,316.93. Following the sale, the executive vice president now owns 7,215 shares of the company’s stock, valued at approximately $961,687.35. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 22,917 shares of company stock valued at $3,050,082 over the last three months. 4.60% of the stock is owned by company insiders.

Addus HomeCare Trading Down 1.7 %

Shares of NASDAQ ADUS opened at $125.80 on Monday. The stock has a market capitalization of $2.28 billion, a price-to-earnings ratio of 31.22, a P/E/G ratio of 2.33 and a beta of 1.04. Addus HomeCare Co. has a 12-month low of $78.35 and a 12-month high of $136.12. The firm’s 50-day moving average price is $130.54 and its 200-day moving average price is $119.40.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings data on Monday, August 5th. The company reported $1.35 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.21 by $0.14. The business had revenue of $286.90 million for the quarter, compared to the consensus estimate of $284.90 million. Addus HomeCare had a return on equity of 9.81% and a net margin of 6.18%. The company’s quarterly revenue was up 10.4% compared to the same quarter last year. During the same period in the prior year, the business posted $0.94 earnings per share. On average, equities analysts predict that Addus HomeCare Co. will post 4.58 EPS for the current fiscal year.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.